Germany’s Bayer closes Monsanto deal, plans to drop US company’s name
There are much better ways to invest in cheap healthcare stocks at the moment. Meanwhile, Bayer announced in May that it reached verbal agreements to settle between 50,000 to 85,000 of its pending glyphosate cases for a total of $10 billion. Whether everyone will be on board with the idea, however, is unknown. While Bayer was